Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy

24 Jul 2012

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to HIV/AIDS drug development and treatment
Share to HIV/AIDS Research and Interventions
Share to HIV Research and Treatment

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 22837004
DOI: 10.1038/nature11286

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapyPMID 22837004Read ↗

Interval dosing with the HDAC inhibitor vorinostat effectively reverses HIV latencySemantic proximity Read ↗

Modeling the Effects of Vorinostat In Vivo Reveals both Transient and Delayed HIV Transcriptional Activation and Minimal Killing of Latently Infected CellsSemantic proximity Read ↗

Curing HIV: Pharmacologic Approaches to Target HIV-1 LatencySemantic proximity Read ↗

Assessing the impact of AGS-004, a dendritic cell-based immunotherapy, and vorinostat on persistent HIV-1 InfectionSemantic proximity Read ↗

Stable Latent HIV Infection and Low-level Viremia Despite Treatment With the Broadly Neutralizing Antibody VRC07-523LS and the Latency Reversal Agent VorinostatSemantic proximity Read ↗

Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapySemantic proximity Read ↗

Therapeutics for HIV-1 reactivation from latencySemantic proximity Read ↗

Targeting HIV latency: pharmacologic strategies toward eradicationSemantic proximity Read ↗

Mechanisms of inhibition of HIV replication by non-nucleoside reverse transcriptase inhibitorsSemantic proximity Read ↗

Infection by zidovudine-resistant HIV-1 compromises the virological response to stavudine in a drug-naive patient.Semantic proximity Read ↗

Pegylated Interferon Alfa-2a Monotherapy Results in Suppression of HIV Type 1 Replication and Decreased Cell-Associated HIV DNA IntegrationSemantic proximity Read ↗

Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trialSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.